Say goodbye to AbbVie's ever-growing Humira sales: The biosim decline has officially begun

AbbVie's Humira just posted its first-ever drop in worldwide sales—and with biosimilars on the march in Europe, it's not likely to be the last. That's a big switch for the megablockbuster, which has a history of double-digit growth.